- Home
- CLDX vs DX Comparison
CLDX vs DX Comparison
Compare CLDX & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | DX |
|---|---|---|
| Founded | N/A | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.2B |
| IPO Year | 1995 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CLDX | DX |
|---|---|---|
| Price | $38.43 | $12.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $46.60 | $14.75 |
| AVG Volume (30 Days) | 678.9K | ★ 4.8M |
| Earning Date | 05-04-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 15.11% |
| EPS Growth | N/A | ★ 65.77 |
| EPS | N/A | ★ 0.45 |
| Revenue | ★ $12,743,000.00 | N/A |
| Revenue This Year | $111.39 | N/A |
| Revenue Next Year | $235.85 | N/A |
| P/E Ratio | ★ N/A | $27.18 |
| Revenue Growth | ★ 87.78 | N/A |
| 52 Week Low | $22.10 | $11.83 |
| 52 Week High | $45.14 | $14.93 |
Technical Indicators
Market Signals| Indicator | CLDX | DX |
|---|---|---|
| Relative Strength Index (RSI) | 45.97 | 26.73 |
| Support Level | $28.51 | $12.14 |
| Resistance Level | $40.30 | $13.29 |
| Average True Range (ATR) | 1.37 | 0.17 |
| MACD | -0.29 | -0.07 |
| Stochastic Oscillator | 31.63 | 3.66 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About DX Dynex Capital Inc.
Dynex Capital Inc is a real estate investment trust (REIT) focused on delivering dividends supported by long term returns from investments in mortgage assets backed by U.S. housing and commercial real estate. The Company is internally managed and mainly invests in residential and commercial mortgage-backed securities (RMBS and CMBS), which are Agency securities guaranteed by U.S. government-sponsored enterprises (GSEs). It manages interest rate, prepayment, spread, liquidity, and counterparty risks and operates through one reportable segment investing in MBS funded with repurchase agreements and equity.